TENCIBAVI Trademark

Trademark Overview

On Tuesday, December 29, 2020, a trademark application was filed for TENCIBAVI with the United States Patent and Trademark Office. The USPTO has given the TENCIBAVI trademark a serial number of 90426716. The federal status of this trademark filing is REGISTERED as of Tuesday, October 4, 2022. This trademark is owned by Takeda Pharmaceuticals International AG. The TENCIBAVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases
tencibavi

General Information

Serial Number90426716
Word MarkTENCIBAVI
Filing DateTuesday, December 29, 2020
Status700 - REGISTERED
Status DateTuesday, October 4, 2022
Registration Number6861970
Registration DateTuesday, October 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 19, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases
Translation of Words in MarkThe wording "Tencibavi" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTakeda Pharmaceuticals International AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH
Party NameTakeda Pharmaceuticals International AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH
Party NameTakeda Pharmaceuticals International AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGlattpark-Opfikon 8152
CH

Trademark Events

Event DateEvent Description
Tuesday, October 4, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 4, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, August 31, 20221(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, August 29, 2022NOTICE OF ALLOWANCE CANCELLED
Wednesday, August 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 29, 2022TEAS DELETE 1(B) BASIS RECEIVED
Friday, April 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022SOU EXTENSION 1 GRANTED
Wednesday, March 30, 2022SOU EXTENSION 1 FILED
Wednesday, March 30, 2022TEAS EXTENSION RECEIVED
Tuesday, December 14, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 19, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 29, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 16, 2021ELECTRONIC RECORD REVIEW COMPLETE
Friday, August 20, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, August 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 11, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, August 10, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 10, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, August 10, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 20, 2021ASSIGNED TO LIE
Wednesday, June 30, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 28, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 28, 2021LETTER OF SUSPENSION E-MAILED
Monday, June 28, 2021SUSPENSION LETTER WRITTEN
Saturday, June 26, 2021ASSIGNED TO EXAMINER
Monday, March 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 1, 2021NEW APPLICATION ENTERED IN TRAM

Related Keywords

tencibavi diseases infectious treatment preparations pharmaceutical